The development of new antigen detection systems which claim to identify GAS directly from throat swabs seems to have the potential for improving the management of patients with acute sore throats, because the identification of GAS is made within 10 to 70 min of taking the swab from the patient.
There are approximately 27 million throat swabs processed annually in the United States. Two recent studies have reported that, despite broad use of throat cultures for the detection of group A streptococci (GAS), throat swabs processed by conventional means have very little impact on the management of patients (5, 12) . Holmberg and Faich (12) , in their survey of physicians practicing in Rhode Island, reported that 87% of primary-care physicians prescribed antimicrobial therapy before culture results were known and that 40% continued antimicrobial therapy for 10 days regardless of culture results. These authors concluded that current throat-culturing practices probably have very little influence on the treatment of streptococcal pharyngitis in the state. Cochi et al. (5) , in a nationwide survey of practicing physicians, reported that 25% of physicians always take specimens for culture, 52% selectively do so, and 23% never do so for patients with acute sore throats. Pediatricians were more likely to always take culture specimens (54%) and less likely (5%) to never take culture specimens. When primary-care physicians were asked whether they begin treatment before culture results are known, 42% said yes, always; 55% said yes, selectively; and 3% said no. When physicians who took throat cultures were asked whether they discontinued antimicrobial therapy if the culture was negative, 58% said yes and 42% said no. From these responses, we can conclude that throat cultures as they are now used in the United States have very little impact on the management of patients.
For any microbiologic test to be useful, it should have some influence on the management of patients. The most often stated reason for not using the results of conventional throat cultures to influence the decision to prescribe or not to prescribe antimicrobial therapy was the delay in getting the culture results (5).
The development of new antigen detection systems which claim to identify GAS directly from throat swabs seems to have the potential for improving the management of patients with acute sore throats, because the identification of GAS is made within 10 to 70 min of taking the swab from the patient.
Some of these kits have been evaluated for specificity and sensitivity in various clinical settings (2-4, 8-11, 13, 27, 28 Table 3 . Note that the authors of some of these reports used selective media, whereas others did not. Also note that the authors of these reports used three different incubation atmospheres for their "conventional" isolation procedures.
All the reports in part A of Table 3 used the Culturette 10-Minute GAS identification procedure. The specificities ranged from 88 to 100%, but most (10 of 12 reports) were between 95.5 and 99.0% specific. My results with two lots of this product were 97.8 and 98.7% specific.
There are seven reports about the Directigen GAS detection system. The unpublished report is a study performed by a colleague. The specificities mentioned in the published reports were 98 to 99%. The specificity of the one lot of Directigen GAS reagents evaluated in this study was 100%.
Two studies have evaluated the Detect-A-Strep GAS kit. The specificity of the Detect-A-Strep product evaluated in this study was 100% (two lots). The specificities reported by the other authors were 96.5 and 98.6% (Table 3 , part C).
Three of the five studies, each using a different product, summarized in Table 3 , part D, reported specificities nearly identical to those observed in this study. The specificity of the Phadirect Strep A test reported by Ogay and Bille (19) was lower than I observed, but these authors delayed processing some of the swabs. This could have altered both the conventional and direct antigen test results. The specificity of the Strep-A-Fluor test was also low (78%). I did not calculate the specificity of the Strep-A-Fluor test in the present study, because the data could be easily manipulated by the choice of test strains. The Strep-A-Fluor test is based on detection of the enzyme PYRase, which is known to occur not only in group A Streptococcus but in Enterococcus and Staphylococcus species as well. The results of Gerber et al. (10) indicate that either enterococci or staphylococci are among the bacteria found in the oral cavity that may give positive PYRase reactions. It is dubious whether this test should be used as a direct test for the identification of GAS.
I have also listed the sensitivities reported by the authors of these studies in Table 3 . There is a wide range of results, 62 to 100% sensitive. Even studies using the same product with the same conventional procedure have a difference of 20% in sensitivity (Roddey et al. [21] versus Schwartz et al. [22] ). There is a general trend that the products using enzymes for extraction ( 
